Search

everythinglearnresearchcommunity

for

Search:↓

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

A patient lost all their hair while on rheumatoid arthritis medication.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

New understanding and treatments for hair loss are improving, but more research is needed.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Adalimumab can cause complete hair loss in rare cases.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

Women with androgenetic alopecia may have higher blood pressure levels.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.